"V\u00FDznam farmakologick\u00E9 intervence srde\u010Dn\u00ED frekvence v l\u00E9\u010Db\u011B kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED" . "I" . . "verapamil; beta-blockers; ivabradine; heart failure; myocardia ischemia; heart rate"@en . "Heart rate is the independent factor affecting ischemic load in patients with angina and the rate of cardiovascular events in patients with chronic heart failure. During pharmacological intervention as part of prophylaxis for myocardial ischemia in patients with angina, a reduction of ischemic load has been documented for booth treatment with beta-blockers and with ivabradine. The treaqtment of chronic heart failure with negative chronotropic e\u0161ffect - beta-blockers and ivabradine - fauvorably affected cardiovascular mortality and morbidity."@en . . "V\u00FDznam farmakologick\u00E9 intervence srde\u010Dn\u00ED frekvence v l\u00E9\u010Db\u011B kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED"@cs . . "1"^^ . . "180180" . . "9"^^ . "Significance of pharmacological intervention for heart rate treating cardiovascular disease"@en . . . . "CZ - \u010Cesk\u00E1 republika" . "RIV/00216208:11120/12:43907074!RIV13-MSM-11120___" . "RIV/00216208:11120/12:43907074" . "V\u00FDznam farmakologick\u00E9 intervence srde\u010Dn\u00ED frekvence v l\u00E9\u010Db\u011B kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED" . "5-6" . "Srde\u010Dn\u00ED frekvence je nez\u00E1visl\u00FDm faktorem ovliv\u0148uj\u00EDc\u00EDm ischemickou z\u00E1t\u011B\u017E u nemocn\u00FDch s anginou pectoris a v\u00FDskyt kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u nemocn\u00FDch s chronick\u00FDm srde\u010Dn\u00EDm selh\u00E1n\u00EDm. P\u0159i dlouhodob\u00E9m sledov\u00E1n\u00ED zdrav\u00E9 populace je dolo\u017Eena z\u00E1vislost celkov\u00E9 i kardiovaskul\u00E1rn\u00ED mortality na v\u00FDchoz\u00ED srde\u010Dn\u00ED frekvenci. P\u0159i farmakologick\u00E9 intervenci v r\u00E1mci profylaxe myokardi\u00E1ln\u00ED ischemie u nemocn\u00FDch s anginou pectoris je dolo\u017Eeno sn\u00ED\u017Een\u00ED ischemick\u00E9 z\u00E1t\u011B\u017Ee jak p\u0159i l\u00E9\u010Db\u011B beta-blok\u00E1tory, tak p\u0159i l\u00E9\u010Db\u011B ivabradinem. Zda p\u0159i l\u00E9\u010Db\u011B ivabradinem je p\u0159\u00EDzniv\u011B ovlivn\u011Bn t\u00E9\u017E v\u00FDskyt kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod a mortality, je prov\u011B\u0159ov\u00E1no v prob\u00EDhaj\u00EDc\u00ED studii SIGNIFY. L\u00E9\u010Dba chronick\u00E9ho srde\u010Dn\u00EDho selh\u00E1n\u00ED l\u00E9ky s negativn\u00EDm chronotropn\u00EDm \u00FA\u010Dinkem - beta-blok\u00E1tory a ivabradinem - p\u0159\u00EDzniv\u011B ovlivnila kardiovaskul\u00E1rn\u00ED morbiditu i mortalitu. Farmakologick\u00E1 intervence zv\u00FD\u0161en\u00E9 srde\u010Dn\u00ED frekvence se tak za\u0159adila mezi standardn\u00ED l\u00E9\u010Debn\u00E9 postupy v l\u00E9\u010Db\u011B \u0159ady kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED."@cs . . . "1213-807X" . "[2A547BA3270B]" . "11120" . . . "Significance of pharmacological intervention for heart rate treating cardiovascular disease"@en . . "Interven\u010Dn\u00ED a akutn\u00ED kardiologie" . "Bultas, Jan" . . . . "V\u00FDznam farmakologick\u00E9 intervence srde\u010Dn\u00ED frekvence v l\u00E9\u010Db\u011B kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED"@cs . "11" . . "1"^^ . . "Srde\u010Dn\u00ED frekvence je nez\u00E1visl\u00FDm faktorem ovliv\u0148uj\u00EDc\u00EDm ischemickou z\u00E1t\u011B\u017E u nemocn\u00FDch s anginou pectoris a v\u00FDskyt kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod u nemocn\u00FDch s chronick\u00FDm srde\u010Dn\u00EDm selh\u00E1n\u00EDm. P\u0159i dlouhodob\u00E9m sledov\u00E1n\u00ED zdrav\u00E9 populace je dolo\u017Eena z\u00E1vislost celkov\u00E9 i kardiovaskul\u00E1rn\u00ED mortality na v\u00FDchoz\u00ED srde\u010Dn\u00ED frekvenci. P\u0159i farmakologick\u00E9 intervenci v r\u00E1mci profylaxe myokardi\u00E1ln\u00ED ischemie u nemocn\u00FDch s anginou pectoris je dolo\u017Eeno sn\u00ED\u017Een\u00ED ischemick\u00E9 z\u00E1t\u011B\u017Ee jak p\u0159i l\u00E9\u010Db\u011B beta-blok\u00E1tory, tak p\u0159i l\u00E9\u010Db\u011B ivabradinem. Zda p\u0159i l\u00E9\u010Db\u011B ivabradinem je p\u0159\u00EDzniv\u011B ovlivn\u011Bn t\u00E9\u017E v\u00FDskyt kardiovaskul\u00E1rn\u00EDch p\u0159\u00EDhod a mortality, je prov\u011B\u0159ov\u00E1no v prob\u00EDhaj\u00EDc\u00ED studii SIGNIFY. L\u00E9\u010Dba chronick\u00E9ho srde\u010Dn\u00EDho selh\u00E1n\u00ED l\u00E9ky s negativn\u00EDm chronotropn\u00EDm \u00FA\u010Dinkem - beta-blok\u00E1tory a ivabradinem - p\u0159\u00EDzniv\u011B ovlivnila kardiovaskul\u00E1rn\u00ED morbiditu i mortalitu. Farmakologick\u00E1 intervence zv\u00FD\u0161en\u00E9 srde\u010Dn\u00ED frekvence se tak za\u0159adila mezi standardn\u00ED l\u00E9\u010Debn\u00E9 postupy v l\u00E9\u010Db\u011B \u0159ady kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED." .